Cristiana Vignoli, CEO of Hemera, has been awarded the BFactor 2025 Prize as part of the fifth edition of the initiative promoted by the Marisa Bellisario Foundation, under the High Patronage of the European Parliament, the Italian Chamber of Deputies, the Presidency...
During the Life Sciences session on the third day of the STB Days 2025, an event organized by the General Consulate of Italy in Boston to highlight Italian and Italian-American excellence in science, technology, and business, Dr. Ilaria Barone, Senior Researcher at...
Hemera recently participated in the prestigious European program EIC Accelerator, promoted by the European Commission to support high-impact technological innovation on an international scale. Our application focused on the REMaST project, First Regenerative Medicine...
The European patent for REMaST, Hemera’s proprietary technology for nervous tissue regeneration, has been published in Issue 24/25 of the European Patent Office (EPO) Bulletin on June 11, 2025https://www.epo.org/bulletin/downloads/2025/bulletin2524.pdf. The patent...
We are pleased to announce the entry of Statuto Fiduciaria as a new shareholder, representing the subscribers of the SAFE – Simple Agreement for Future Equity – which has reached €500,000. This transaction confirms the strong interest in the Hemera project from...
Hemera is among the 7 Italian startups out of 71 selected across Europe, that successfully passed the second phase of the EIC Accelerator selection process, the prestigious European Union program supporting highly innovative SMEs and startups. Hemera has now received...
